FreshBurst Listerine Study Must Exhibit 20% Gingivitis Reduction – FDA
This article was originally published in The Rose Sheet
Executive Summary
A six-month study of FreshBurst Listerine with Fluoride will need to show "a 20% reduction in gingivitis" over a control to merit agency sign-off, FDA told Pfizer execs at an OTC "feedback" meeting Aug. 27